Skip to Content

UPSHER-SMITH 200 mg (Topiramate Extended-Release 200 mg)

Pill with imprint UPSHER-SMITH 200 mg is Brown / Gray, Capsule-shape and has been identified as Topiramate Extended-Release 200 mg. It is supplied by Upsher-Smith Laboratories, Inc..

Topiramate is used in the treatment of epilepsy; seizure prevention; lennox-gastaut syndrome; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for UPSHER-SMITH 200 mg

Topiramate Extended-Release

Imprint
UPSHER-SMITH 200 mg
Strength
200 mg
Color
Brown / Gray
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Upsher-Smith Laboratories, Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00832-1073 Upsher-Smith Laboratories Inc.
00245-1073 Upsher-Smith Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "UPSHER-SMITH 200 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.